Insufflation Devices Market (2026 - 2033)

Insufflation Devices Market Summary

The global insufflation devices market size was valued at USD 3.1 billion in 2025 and is projected to grow from USD 3.3 billion in 2026 to USD 5.2 billion by 2033, at a CAGR of 6.7% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. The growing demand for insufflation devices is driven by advancements in surgical technology, an increase in surgical procedures, and the rising prevalence of uterine fibroids, obesity, and heart disorders globally. The surge in obesity, linked to sedentary lifestyles and higher consumption of high-fat, high-sugar foods, is a significant contributor to market growth.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Insufflation devices are essential tools in minimally invasive surgeries, as they facilitate the expansion of body cavities by introducing gases such as carbon dioxide. This process enhances visibility and access for surgeons, ultimately improving procedural accuracy and outcomes. Insufflation devices play a crucial role in bariatric surgery by maintaining pneumoperitoneum, which helps reduce clinical risks and operating time while optimizing abdominal pressure. Their use is preferred in various surgical procedures, including laparoscopic and cardiac surgeries, which is expected to drive market growth due to rising global demand for these procedures and their associated benefits. For instance, the American Society for Metabolic and Bariatric Surgery (ASMBS) reported that approximately 270,089 metabolic and bariatric procedures were performed in the U.S. in 2025.

Given the updated guidelines from the ASMBS and the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), the demand for insufflation devices is likely to increase. These expanded guidelines recommend metabolic and bariatric surgery for individuals with a BMI of 35 kg/m² or higher, regardless of the presence or severity of obesity-related conditions. They also suggest considering surgery for those with a BMI of 30–34.9 kg/m² who have metabolic diseases. This broader eligibility criterion is anticipated to drive market growth as healthcare providers respond to the increasing demand for minimally invasive surgical options for obesity and metabolic disorders.

Additionally, the use of insufflation devices in cardiac surgery aims to reduce postoperative complications such as myocardial dysfunction, cerebral injury, and dysrhythmias, which is expected to further boost market growth. According to the American Heart Association's 2025 Heart Disease and Stroke Statistics Update, cardiovascular disease remains the leading cause of death globally, accounting for approximately 941,652 deaths in the United States in 2022. This underscores the ongoing need for advanced cardiac interventions, thereby indirectly driving demand for insufflation devices.

The insufflation device market is also significantly driven by the increasing prevalence of laparoscopic procedures. Laparoscopy, a minimally invasive surgical technique, requires the creation and maintenance of a pneumoperitoneum, an artificial cavity in the abdomen, for optimal visualization and instrument manipulation. Insufflation devices are vital in this process, as they introduce carbon dioxide (CO2) into the abdominal cavity to create the necessary space for surgeons to operate effectively. In the U.S., about 15 million laparoscopic procedures are conducted annually, making it one of the most frequently performed surgeries, according to surgeons at North Kansas City Hospital & Meritas Health.

Analyst Perspective

The insufflation devices market is becoming increasingly important as minimally invasive procedures continue to replace traditional open surgeries across multiple specialties. Hospitals are placing greater emphasis on surgical technologies that improve procedural efficiency, patient safety, and clinical outcomes while reducing recovery time. This is increasing demand for insufflation systems that provide precise pressure control, stable gas flow, and reliable performance during surgery. Companies with strong product innovation, established relationships with healthcare providers, and comprehensive surgical portfolios are likely to strengthen their market position.

End Use Insights

The microscopy segment held the largest market share of over 20.0% in 2025. This growth is driven by advancements in microscopy technology, which have enabled high-resolution imaging systems that provide detailed visualization during minimally invasive procedures. Additionally, the rising prevalence of chronic diseases and the increase in endoscopic surgical procedures have heightened demand for insufflation devices with integrated microscopy capabilities, ultimately enhancing procedural outcomes.

For example, in May 2024, Olympus launched new diagnostic and therapeutic bronchoscopes compatible with the EVIS X1 Endoscopy System. These bronchoscopes feature native HDTV imaging and support technologies such as Texture and Color Enhancement Imaging (TXI), Red Dichromatic Imaging (RDI), Narrow Band Imaging (NBI), and BAI-MAC. These advancements improve the visualization of mucosal structures, vascular patterns, and bleeding points during bronchoscopic procedures. This launch underscores ongoing innovation in advanced endoscopic imaging for respiratory diagnostics and therapeutic interventions, significantly improving visualization of tissues and anatomical structures, thereby enhancing procedural precision and clinical outcomes.

The communication segment is expected to experience the fastest CAGR over the forecast period. The increasing adoption of advanced technologies, such as wireless connectivity and remote monitoring capabilities, primarily drives this segment's growth. These technologies allow healthcare providers to communicate more effectively with devices, enhancing patient outcomes and operational efficiency. Furthermore, the growing emphasis on interoperability and data integration within healthcare systems also supports market growth. Additionally, the rising demand for telemedicine services has increased the need for enhanced communication features in insufflation devices to enable real-time consultations and remote support.

Application Insights

The laparoscopic surgery segment accounted for over 35.0% in 2025 and is expected to grow notably during the forecast period. Continuous improvements in insufflation device technology have enhanced their safety, efficiency, and user-friendliness. Advanced insufflators help regulate gas flow to optimal pressure levels and offer greater accuracy during procedures and practices. According to the study published by Springer Nature Limited in January 2024, the insufflation tube of the AirSeal system during laparoscopic surgery enhances performance by reducing fogging and maintaining clearer visibility, thereby improving surgical outcomes. Such advancements in insufflation technology drive market growth by addressing critical surgical challenges and improving efficiency and safety in minimally invasive procedures.

Integrated smoke extraction systems help remove surgical smoke, improving visibility for surgeons and reducing potential health risks. Insufflation devices offer improved patient monitoring, enabling real-time assessment of vital signs and other parameters during surgery. For instance, the LAP-25 CO2 laparoscopic insufflator from Ecleris enhances laparoscopic surgery by precisely controlling CO2 flow and pressure to maintain a stable pneumoperitoneum. This improves surgical visibility and space management, reducing the risk of complications and enhancing the overall efficiency and safety of minimally invasive procedures. Surgeons are increasingly adopting these advanced devices, which help improve surgical outcomes, reduce complications, and enhance patient safety.

The bariatric surgery segment is expected to grow at the fastest CAGR during the forecast period. Bariatric surgery plays a significant role in driving the insufflation devices market due to the increasing prevalence of obesity and the rising number of weight-loss surgeries. In April 2025, Olympus introduced the UHI-4 High Flow Insufflation Unit in additional global markets, offering stable pneumoperitoneum, high-flow CO₂ delivery, and integrated smoke evacuation to improve visualization and procedural efficiency during laparoscopic surgery. The launch reflects growing demand for advanced insufflation systems that support complex minimally invasive procedures. Therefore, this leads to an increase in the insufflation devices market due to the rising number of weight-loss surgeries among both youth and adults.

Regional Insights

North America dominated the insufflation devices market, accounting for the largest share of revenue at 35.0% in 2025. Greater preference for laparoscopic treatment over open surgery is one of the major drivers of the market. In addition, the laparoscopic devices market would be affected by competition among leading manufacturers in terms of product innovation. Additionally, laparoscopy promotes rapid healing and effective results; surgeons are now choosing it over conventional treatments. Furthermore, rising healthcare costs in the U.S. may encourage new and existing competitors to enter the market.

To learn more about this report, Download Free Sample Report

U.S. Insufflation Devices Market Trends

The insufflation device market in the U.S. dominated North America with the largest market share in 2025, driven by the rising prevalence of minimally invasive surgeries, advancements in medical technology, and increasing demand for laparoscopic procedures. In addition, a growing senior population and the adoption of innovative surgical techniques further fuel market growth.

Asia Pacific Insufflation Devices Market Trends

The laparoscopic equipment market in the Asia Pacific is expected to grow strongly during the forecast period due to the expansion of modern, well-equipped hospitals and an increase in surgical procedures. In addition, the Asia Pacific market is heavily influenced by the growing popularity of global market players in clinical trials and by high R&D investments, driven by their favorable cost structures. Growing awareness of minimally invasive surgeries and patient acceptance of outpatient surgeries are expected to boost the market growth in this region.

The China insufflation device market is primarily driven by the increasing prevalence of minimally invasive surgeries and advancements in medical technology. In addition, the rising healthcare expenditure and expanding medical infrastructure further contribute to market growth.

Key Insufflation Devices Company Insights

Some of the key players in the insufflation device market include Medtronic, B. Braun SE, STERIS, Olympus Corporation, and others. Major players are adopting strategies such as mergers and acquisitions, partnerships, and the launch of new, technologically advanced products and services to strengthen their market foothold.

Key Insufflation Devices Companies

The following key companies have been profiled for this study on the insufflation devices market:

• FUJIFILM Holdings Corporation

• Medtronic plc

• Stryker Corporation

• Becton, Dickinson and Company

• Olympus Corporation

• B. Braun SE

• Smith & Nephew plc

• KARL STORZ SE & Co. KG

• STERIS plc

• CONMED Corporation

• Richard Wolf GmbH

Recent Developments

• In April 2025, FUJIFILM India launched the ELUXEO 8000 Therapeutic Endoscopy System during the 22nd Mumbai Live Endoscopy 2025 convention. The next-generation platform features 4K imaging, Amber-red Color Imaging (ACI), and advanced noise reduction technologies to support minimally invasive gastrointestinal procedures, reflecting continued advancements in endoscopic visualization systems used alongside insufflation technologies.
• In January 2025, Olympus Corporation expanded the availability of its VISERA ELITE III surgical visualization platform across additional global markets. Designed for laparoscopic and endoscopic procedures, the platform integrates with Olympus insufflation and energy devices to enhance visualization, workflow efficiency, and precision during minimally invasive surgeries.

Global Insufflation Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global insufflation devices market report based on application, end use, and region:

• Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Laparoscopic Surgery

  • Bariatric Surgery

  • Cardiac Surgery

  • Other Surgeries

• End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Ophthalmology

  • Microscopy

  • Laser Application

  • Manufacturing

  • Communications

  • Military & Defense

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait